article thumbnail

Abelacimab Stops Bleeding, But Stroke Impact Uncertain

CardiacWire

Fully published results from Athos Therapeutics AZALEA-TIMI 71 trial for its novel Factor XI inhibitor abelacimab, confirming the drugs lower bleeding risks, but leaving researchers uncertain about its ability to prevent stroke in AFib patients. vs. 0.4%) and 4X ischemic stroke rates (csHR = 4.06). year follow-up. per 100 person-year.

Stroke 59
article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Random-effects meta-analyses examined the pooled risk difference in the prevalence of each symptom or symptom combination in cases with confirmed SARS-coV-2 infection compared with controls.ResultsEight cohort studies were eligible, including nearly 10 million people.

article thumbnail

Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association

Stroke Journal

Stroke, Ahead of Print. Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The clinical presentation of cerebral venous thrombosis is diverse (eg, headaches, seizures), requiring a high level of clinical suspicion. The clinical course of cerebral venous thrombosis may be difficult to predict.

article thumbnail

New evidence informs risk factors, diagnosis and care of patients with CVT stroke

American Heart News - Stroke News

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.

article thumbnail

Standing more may not reduce cardiovascular disease risk, could increase circulatory disease, research finds

Science Daily - Heart Disease

New research has shown that over the long-term, standing more compared with sitting does not improve cardiovascular health (coronary heart disease, stroke and heart failure), and could increase the risk of circulatory issues related to standing, such as varicose veins and deep vein thrombosis.

Research 119
article thumbnail

Red light linked to lowered risk of blood clots

Medical Xpress - Cardiology

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by University of Pittsburgh School of Medicine and UPMC surgeon-scientists and published today in the Journal of Thrombosis and Haemostasis.

article thumbnail

The WATCHMAN, Left Atrial Appendage Occluder, and Device Related Thrombosis

Dr. Anish Koka

The left atrial appendage dangles off the left atrial chamber in the heart and has long been suspected of being a nidus for clot that can break off and cause a stroke. In a prior age, there were no good options for these patients, and doctors and families were reduced to prayer to prevent strokes from occurring.